Seeing Is Believing
Currently out of the existing stock ratings of Gena Wang, 207 are a BUY (67.65%), 69 are a HOLD (22.55%), 30 are a SELL (9.8%).
Analyst Gena Wang, currently employed at BARCLAYS, carries an average stock price target met ratio of 62.95% that have a potential upside of 23.81% achieved within 177 days.
Gena Wang’s has documented 600 price targets and ratings displayed on 43 stocks. The coverage is on Healthcare, Energy, Technology sectors.
Most recent stock forecast was given on SRPT, Sarepta Therapeutics at 17-Jun-2025.
Analyst best performing recommendations are on SMCI (SUPER MICRO COMPUTER).
The best stock recommendation documented was for SMCI (SUPER MICRO COMPUTER) at 2/13/2024. The price target of $961 was fulfilled within 2 days with a profit of $169.51 (21.42%) receiving and performance score of 107.08.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$338
$28.3 (9.14%)
$328
13 days ago
(12-Jun-2025)
4/6 (66.67%)
$33.33 (10.94%)
7
Buy
$325
$15.3 (4.94%)
$300
1 months 23 days ago
(02-May-2025)
11/12 (91.67%)
$65.61 (25.29%)
270
Hold
$268
$-41.7 (-13.46%)
$284
2 months 14 days ago
(11-Apr-2025)
10/10 (100%)
$30.23 (12.71%)
39
Buy
$320
$10.3 (3.33%)
$320
2 months 16 days ago
(09-Apr-2025)
12/20 (60%)
$76.73 (31.54%)
215
Buy
$500
$190.3 (61.45%)
$500
2 months 23 days ago
(02-Apr-2025)
1/25 (4%)
$233.17 (87.39%)
664
Which stock is Gena Wang is most bullish on?
Which stock is Gena Wang is most reserved on?
What Year was the first public recommendation made by Gena Wang?